iberdomide
bms
['lupus', 'iberdomide']
recommended reading: iberdomide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled, ascending-dose, phase 2a study #acr22 
The official #OpenAccess journal of the @LupusOrg published by @BMJ_company creating a barrier-free forum for #lupus #research